Novo Nordisk says high-dose experimental obesity pill leads to 15% weight loss
June 26, 2023 at 09:33 AM EDT
Novo Nordisk's pill is an oral version of semaglutide, the active ingredient in the Danish company's blockbuster weight loss injections Ozempic and Wegovy.